Unknown OBSERVATIONAL NCT04454580

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Retrospective, Observational, Monocentric Study to Assess Efficacy and Safety of the Combination of an Hypomethylating Agent in Combination With Venetoclax for Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Sponsor: Ospedale Maggiore Di Trieste

Conditions Acute Myeloid Leukemia, Adult Hypomethylating Agents Venetoclax

Interventions Venetoclax

Updated 6 times since 2020 Last updated: Sep 14, 2020 Started: Aug 1, 2020 Primary completion: Sep 16, 2020 Completion: Sep 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Myeloid Leukemia, Adult and Hypomethylating Agents and is currently ongoing. Ospedale Maggiore Di Trieste leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting
Oct 2020 — Jan 2021 [monthly]

Recruiting

▶ Show 1 earlier version

Aug 2020 — Oct 2020 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ospedale Maggiore Di Trieste

Data source: Ospedale Maggiore Di Trieste

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trieste, Italy